Journal of Experimental & Clinical Cancer Research

Table 2 Clinical characteristic of patients with TNBC and DNBC patient cohort for PCR-array screening profile and plasma qRT-PCR validation lot

From: Aberrant miRNAs expressed in HER-2 negative breast cancers patient

No	TNM stage	Age
TNBC
1	T4bN1 M0	56
2	T2N0M0	59
3	T4bN2Mx	40
4	T2N0M0	52
5	T2 N1 M0	46
6	T2N0M0	53
7	T2 N1 M0	56
8	T3 N1 M0	46
9	T4bN1 M0	57
10	T3 N1 M0	50
11	T4bN2Mx	57
12	T4bN2M0	55
13	T2 N1 M0	35
14	T4cN2Mx	59
15	T2 N1 M0	48
16	T4bN1 M0	50
17	T2 N1 M0	51
18	T3 N1 M0	59
19	T3 N1 M0	45
20	T4bN1 M0	56
21	T3 N1 M0	53
DPBC
1	T2N1aMx	59
2	T2 N1 M0	69
3	T3N1Mx	60
4	T2N0Mx	39
5	T4bN3aMx	73
6	T2N0M0	49
7	T2N0Mx	42
8	T3N1Mx	58
9	T2 N1 M0	41
10	T1N0Mx	67
11	T4bN1 M0	66
12	T3N1Mx	52
13	T2N2aMx	57
14	T4bN1 M0	52
15	T1N0Mx	42
16	T4bN1 M0	38
17	T2N1Mx	62
18	T2N0M0	46
19	T3N0M0	57
20	T2N2aMx	48
21	T2 N1 M0	64
22	T3N1Mx	63
23	T2N0M0	62
24	T4N3bMx.	70
25	T2N0M0	62
26	T3N1aMx	66
27	T1N0M0	69
28	T3N1Mx	45
29	T2 N1 M0	44
30	T3N1Mx	36
31	T2N0M0	42
32	T3N0Mx	47
33	T2N1Mx	47
34	T2 N1 M0	41
35	T4N2Mx	51
36	T2 N1 M0	44
37	T4N2Mx	45
38	T3N0Mx	37
39	T4N2Mx	73
40	T3N1Mx	40
41	T4N2Mx	49
42	T4N1Mx	56
43	T3N3Mx.	80
44	T3N3Mx.	49
45	T4N2Mx	59
46	T3N0Mx	49
47	T2 N1 M0	59

Back to article page

ISSN: 1756-9966

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com